Financial Survey: TerrAscend (OTCMKTS:TRSSF) and Grown Rogue International (OTCMKTS:GRUSF)

TerrAscend (OTCMKTS:TRSSF) and Grown Rogue International (OTCMKTS:GRUSF) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for TerrAscend and Grown Rogue International, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TerrAscend	0	1	2	0	2.67
Grown Rogue International	0	0	0	0	N/A

Profitability

This table compares TerrAscend and Grown Rogue International’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TerrAscend	-125.03%	-6.66%	-3.07%
Grown Rogue International	-1.70%	-3.71%	-1.67%

Valuation & Earnings

This table compares TerrAscend and Grown Rogue International’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TerrAscend	$247.83 million	1.79	-$329.91 million	N/A	N/A
Grown Rogue International	$23.35 million	6.05	-$130,000.00	$0.01	71.07

Grown Rogue International has lower revenue, but higher earnings than TerrAscend.

Volatility & Risk

TerrAscend has a beta of 2.89, suggesting that its stock price is 189% more volatile than the S&P 500. Comparatively, Grown Rogue International has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500.

Insider & Institutional Ownership

0.0% of TerrAscend shares are held by institutional investors. Comparatively, 9.3% of Grown Rogue International shares are held by institutional investors. 32.9% of TerrAscend shares are held by company insiders. Comparatively, 23.2% of Grown Rogue International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Grown Rogue International beats TerrAscend on 6 of the 10 factors compared between the two stocks.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey. In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands. It serves medical and legal adult-use markets. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

About Grown Rogue International

Grown Rogue International Inc., together with its subsidiaries, produces and sells cannabis products in the United States. It offers a range of cultivars for consumers, such as indicas, sativas, and hybrids; strain-specific prepackaged flowers; and pre-roll pack products, as well as provides consulting services. The company sells its products through direct-to-retail delivery and third-party delivery, wholesalers, and processors. Grown Rogue International Inc. is headquartered in Medford, Oregon.